Cardinal Health (0HTG) Ratios
Cardinal Health Ratios
GB:0HTG's free cash flow for Q4 2026 was $1.43B. For the 2026 fiscal year, GB:0HTG's free cash flow was decreased by $-264.00M and operating cash flow was $1.69B. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.88 | 0.94 | 0.98 | 1.00 | 1.08 |
| Quick Ratio | 0.49 | 0.50 | 0.56 | 0.52 | 0.57 |
| Cash Ratio | 0.11 | 0.10 | 0.14 | 0.12 | 0.15 |
| Solvency Ratio | 0.04 | 0.04 | 0.03 | 0.02 | -0.01 |
| Operating Cash Flow Ratio | 0.12 | 0.06 | 0.11 | 0.08 | 0.10 |
| Short-Term Operating Cash Flow Coverage | 2.82 | 3.36 | 6.83 | 3.19 | 4.58 |
| Net Current Asset Value | $ -21.27B | $ -19.38B | $ -13.45B | $ -12.57B | $ -11.65B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.18 | 0.12 | 0.12 | 0.13 |
| Debt-to-Equity Ratio | -3.45 | -3.36 | -1.75 | -1.75 | -8.19 |
| Debt-to-Capital Ratio | 1.41 | 1.42 | 2.34 | 2.33 | 1.14 |
| Long-Term Debt-to-Capital Ratio | 1.72 | 1.55 | 3.35 | 4.32 | 1.18 |
| Financial Leverage Ratio | -19.87 | -19.10 | -14.04 | -14.65 | -61.89 |
| Debt Service Coverage Ratio | 1.38 | 2.77 | 2.68 | 1.13 | -0.12 |
| Interest Coverage Ratio | 7.51 | 10.58 | 24.37 | 8.95 | -4.13 |
| Debt to Market Cap | 0.16 | 0.21 | 0.21 | 0.19 | 0.37 |
| Interest Debt Per Share | 43.63 | 39.67 | 23.10 | 20.15 | 21.33 |
| Net Debt to EBITDA | 1.46 | 1.76 | 0.24 | 0.76 | 19.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 3.84% | 3.67% | 3.27% | 3.36% | 3.58% |
| EBIT Margin | 0.99% | 1.04% | 0.55% | 0.36% | -0.35% |
| EBITDA Margin | 1.37% | 1.40% | 0.86% | 0.70% | 0.03% |
| Operating Profit Margin | 1.03% | 1.02% | 0.55% | 0.37% | -0.33% |
| Pretax Profit Margin | 0.86% | 0.94% | 0.53% | 0.32% | -0.43% |
| Net Profit Margin | 0.67% | 0.70% | 0.38% | 0.16% | -0.52% |
| Continuous Operations Profit Margin | 0.67% | 0.70% | 0.38% | 0.16% | -0.52% |
| Net Income Per EBT | 78.84% | 74.30% | 70.94% | 49.77% | 119.64% |
| EBT Per EBIT | 83.20% | 92.35% | 96.62% | 88.16% | 129.16% |
| Return on Assets (ROA) | 2.99% | 2.94% | 1.89% | 0.76% | -2.14% |
| Return on Equity (ROE) | -59.45% | -56.13% | -26.52% | -11.16% | 132.30% |
| Return on Capital Employed (ROCE) | 19.51% | 15.99% | 13.11% | 7.83% | -4.55% |
| Return on Invested Capital (ROIC) | 13.24% | 11.37% | 8.80% | 3.58% | -4.33% |
| Return on Tangible Assets | 3.93% | 3.81% | 2.20% | 0.89% | -2.59% |
| Earnings Yield | 3.06% | 3.86% | 3.56% | 1.34% | -6.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 18.40 | 16.81 | 18.77 | 18.45 | 17.17 |
| Payables Turnover | 6.39 | 6.18 | 6.91 | 6.62 | 6.45 |
| Inventory Turnover | 14.13 | 12.74 | 14.67 | 12.29 | 11.18 |
| Fixed Asset Turnover | 63.21 | 77.88 | 89.69 | 83.29 | 76.80 |
| Asset Turnover | 4.44 | 4.19 | 5.03 | 4.73 | 4.13 |
| Working Capital Turnover Ratio | -66.25 | -135.72 | -597.70 | 172.11 | 62.43 |
| Cash Conversion Cycle | -11.50 | -8.73 | -8.51 | -5.67 | -2.73 |
| Days of Sales Outstanding | 19.83 | 21.72 | 19.45 | 19.78 | 21.26 |
| Days of Inventory Outstanding | 25.82 | 28.65 | 24.88 | 29.70 | 32.64 |
| Days of Payables Outstanding | 57.16 | 59.09 | 52.83 | 55.15 | 56.63 |
| Operating Cycle | 45.66 | 50.37 | 44.33 | 49.48 | 53.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 21.92 | 9.95 | 15.36 | 10.90 | 11.19 |
| Free Cash Flow Per Share | 19.17 | 7.68 | 13.27 | 9.05 | 9.80 |
| Dividend Paid and CapEx Coverage Ratio | 4.54 | 2.30 | 3.72 | 2.83 | 3.30 |
| Capital Expenditure Coverage Ratio | 7.97 | 4.38 | 7.36 | 5.91 | 8.07 |
| Operating Cash Flow Coverage Ratio | 0.52 | 0.26 | 0.67 | 0.55 | 0.54 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 |
| Free Cash Flow Yield | 8.07% | 4.57% | 13.57% | 9.57% | 18.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.68 | 25.93 | 28.11 | 74.80 | -15.55 |
| Price-to-Sales (P/S) Ratio | 0.22 | 0.18 | 0.11 | 0.12 | 0.08 |
| Price-to-Book (P/B) Ratio | -19.45 | -14.56 | -7.45 | -8.34 | -20.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.39 | 21.89 | 7.37 | 10.45 | 5.33 |
| Price-to-Operating Cash Flow Ratio | 10.84 | 16.89 | 6.37 | 8.68 | 4.67 |
| Price-to-Earnings Growth (PEG) Ratio | 2.68 | 0.30 | 0.16 | -0.54 | 0.06 |
| Enterprise Value Multiple | 17.58 | 14.80 | 12.45 | 17.92 | 284.93 |
| Enterprise Value | 61.16B | 45.96B | 24.43B | 25.78B | 15.67B |
| EV to EBITDA | 17.58 | 14.80 | 12.45 | 17.92 | 284.93 |
| EV to Sales | 0.24 | 0.21 | 0.11 | 0.13 | 0.09 |
| EV to Free Cash Flow | 13.52 | 24.84 | 7.51 | 10.91 | 5.73 |
| EV to Operating Cash Flow | 11.82 | 19.17 | 6.49 | 9.07 | 5.02 |
| Tangible Book Value Per Share | -69.30 | -61.46 | -39.44 | -34.64 | -29.87 |
| Shareholders’ Equity Per Share | -12.22 | -11.54 | -13.11 | -11.33 | -2.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.25 | 0.29 | 0.50 | -0.20 |
| Revenue Per Share | 1077.32 | 923.56 | 925.82 | 785.36 | 649.91 |
| Net Income Per Share | 7.26 | 6.48 | 3.48 | 1.26 | -3.36 |
| Tax Burden | 0.79 | 0.74 | 0.71 | 0.50 | 1.20 |
| Interest Burden | 0.86 | 0.91 | 0.96 | 0.89 | 1.23 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.03 | 1.53 | 4.41 | 8.59 | -3.35 |
Currency in USD